Post job

Strongbridge Biopharma executives

Here are further demographic highlights of the leadership team:
  • The Strongbridge Biopharma executive team is 33% female and 67% male.
  • 66% of the management team is White.
  • 5% of Strongbridge Biopharma management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at Strongbridge Biopharma?
Share your experience

Rate Strongbridge Biopharma's leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Per Marin M.d

Board Member

Fredric Cohen M.d

Chief Medical Officer

Fredric Cohen is a Chief Medical Ofcr at STRONGBRIDGE BIOPHARMA PLC. He works or has worked at Johnson & Johnson. Fredric studied at Penn State University and Franklin & Marshall College.

John H. Johnson

Board Member

John H. Johnson's LinkedIn

John was appointed to chief executive officer in July 2020. He previously served as executive chairman from November 2019 to July 2020 and as chairman from March 2015 to November 2019. He is a recognized leader in the biopharmaceutical industry with more than 30 years of experience at leading global organizations, including Johnson & Johnson, Eli Lilly & Company, ImClone, and Pfizer, Inc. He currently serves as a member of the board of directors of Verastem, Inc. John previously served on the board of directors of Pharmaceutical Research and Manufacturers of America (PhRMA), the Health Section Governing Board of Biotechnology Industry Organizations (BIO), and BioNJ.

John holds a BS from the East Stroudsburg University of Pennsylvania.

Emily Doyle

Chief Human Resources Officer

Scott Wilhoit

Senior Vice President

Beth Hecht

Board Member

Brian Conner

Chief Compliance Officer

David Gill

Board Member

Garheng Kong

Chairman

Hilde H. Steineger

Board Member

Do you work at Strongbridge Biopharma?

Does the leadership team provide a clear direction for Strongbridge Biopharma?

Strongbridge Biopharma jobs

Strongbridge Biopharma founders

Name & TitleBio
Per Marin M.d

Board Member

Strongbridge Biopharma board members

Name & TitleBio
Per Marin M.d

Board Member

John H. Johnson

Board Member

John H. Johnson's LinkedIn

John was appointed to chief executive officer in July 2020. He previously served as executive chairman from November 2019 to July 2020 and as chairman from March 2015 to November 2019. He is a recognized leader in the biopharmaceutical industry with more than 30 years of experience at leading global organizations, including Johnson & Johnson, Eli Lilly & Company, ImClone, and Pfizer, Inc. He currently serves as a member of the board of directors of Verastem, Inc. John previously served on the board of directors of Pharmaceutical Research and Manufacturers of America (PhRMA), the Health Section Governing Board of Biotechnology Industry Organizations (BIO), and BioNJ.

John holds a BS from the East Stroudsburg University of Pennsylvania.

Beth Hecht

Board Member

David Gill

Board Member

Hilde H. Steineger

Board Member

Jeffrey W. Sherman

Board Member

John Shannon

Board Member

Mårten Steen

Board Member

Steven Pieper

Board Member

Strongbridge Biopharma executives FAQs

Zippia gives an in-depth look into the details of Strongbridge Biopharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Strongbridge Biopharma. The employee data is based on information from people who have self-reported their past or current employments at Strongbridge Biopharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Strongbridge Biopharma. The data presented on this page does not represent the view of Strongbridge Biopharma and its employees or that of Zippia.

Strongbridge Biopharma may also be known as or be related to STRONGBRIDGE BIOPHARMA PLC, Strongbridge Biopharma, Strongbridge Biopharma PLC, Strongbridge Biopharma Plc and Strongbridge Biopharma plc.